- call +1-201-465-4211
- email sales@mrinsights.biz
Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down’s syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening.
Scope of the Report:
This report studies the Prenatal Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prenatal Diagnostics market by product type and applications/end industries.
The global Prenatal Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prenatal Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Hologic
Sequenom
PerkinElmer
Ravgen
Sequenom Center for Molecular Medicine
Abbott Molecular
Angle
TrovaGene
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Harmony PrenaTest
BambniTest
NIFTY (Non-invasive fetal trisomy test)
Verifi
informaSeq
informaSeq Panorama
MaterniT21 PLUS
VisibiliT
Market Segment by Applications, can be divided into
Fetus
Embryos
Newborns
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Prenatal Diagnostics Market Overview
1.1 Product Overview and Scope of Prenatal Diagnostics
1.2 Classification of Prenatal Diagnostics by Types
1.2.1 Global Prenatal Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global Prenatal Diagnostics Revenue Market Share by Types in 2017
1.2.3 Harmony PrenaTest
1.2.4 BambniTest
1.2.5 NIFTY (Non-invasive fetal trisomy test)
1.2.6 Verifi
1.2.7 informaSeq
1.2.8 informaSeq Panorama
1.2.9 MaterniT21 PLUS
1.2.10 VisibiliT
1.3 Global Prenatal Diagnostics Market by Application
1.3.1 Global Prenatal Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Fetus
1.3.3 Embryos
1.3.4 Newborns
1.4 Global Prenatal Diagnostics Market by Regions
1.4.1 Global Prenatal Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Prenatal Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Prenatal Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prenatal Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Prenatal Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prenatal Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Prenatal Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Hologic
2.1.1 Business Overview
2.1.2 Prenatal Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hologic Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sequenom
2.2.1 Business Overview
2.2.2 Prenatal Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sequenom Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 PerkinElmer
2.3.1 Business Overview
2.3.2 Prenatal Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 PerkinElmer Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ravgen
2.4.1 Business Overview
2.4.2 Prenatal Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ravgen Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sequenom Center for Molecular Medicine
2.5.1 Business Overview
2.5.2 Prenatal Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sequenom Center for Molecular Medicine Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott Molecular
2.6.1 Business Overview
2.6.2 Prenatal Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Molecular Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Angle
2.7.1 Business Overview
2.7.2 Prenatal Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Angle Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.8 TrovaGene
2.8.1 Business Overview
2.8.2 Prenatal Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 TrovaGene Prenatal Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Prenatal Diagnostics Market Competition, by Players
3.1 Global Prenatal Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Prenatal Diagnostics Players Market Share
3.2.2 Top 10 Prenatal Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Prenatal Diagnostics Market Size by Regions
4.1 Global Prenatal Diagnostics Revenue and Market Share by Regions
4.2 North America Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
5 North America Prenatal Diagnostics Revenue by Countries
5.1 North America Prenatal Diagnostics Revenue by Countries (2013-2018)
5.2 USA Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe Prenatal Diagnostics Revenue by Countries
6.1 Europe Prenatal Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Prenatal Diagnostics Revenue by Countries
7.1 Asia-Pacific Prenatal Diagnostics Revenue by Countries (2013-2018)
7.2 China Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
8 South America Prenatal Diagnostics Revenue by Countries
8.1 South America Prenatal Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Prenatal Diagnostics by Countries
9.1 Middle East and Africa Prenatal Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Prenatal Diagnostics Revenue and Growth Rate (2013-2018)
10 Global Prenatal Diagnostics Market Segment by Type
10.1 Global Prenatal Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Prenatal Diagnostics Market Forecast by Type (2018-2023)
10.3 Harmony PrenaTest Revenue Growth Rate (2013-2023)
10.4 BambniTest Revenue Growth Rate (2013-2023)
10.5 NIFTY (Non-invasive fetal trisomy test) Revenue Growth Rate (2013-2023)
10.6 Verifi Revenue Growth Rate (2013-2023)
10.7 informaSeq Revenue Growth Rate (2013-2023)
10.8 informaSeq Panorama Revenue Growth Rate (2013-2023)
10.9 MaterniT21 PLUS Revenue Growth Rate (2013-2023)
10.10 VisibiliT Revenue Growth Rate (2013-2023)
11 Global Prenatal Diagnostics Market Segment by Application
11.1 Global Prenatal Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Prenatal Diagnostics Market Forecast by Application (2018-2023)
11.3 Fetus Revenue Growth (2013-2018)
11.4 Embryos Revenue Growth (2013-2018)
11.5 Newborns Revenue Growth (2013-2018)
12 Global Prenatal Diagnostics Market Size Forecast (2018-2023)
12.1 Global Prenatal Diagnostics Market Size Forecast (2018-2023)
12.2 Global Prenatal Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Prenatal Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Prenatal Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Prenatal Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Prenatal Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Prenatal Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Prenatal Diagnostics Picture
Table Product Specifications of Prenatal Diagnostics
Table Global Prenatal Diagnostics and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
